The Bio Report
Levine Media Group
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Is this your show?
Claim it: a verified badge, every new episode summarised to your inbox, and first say over how it is presented here.
Episodes (1239)
Attacking IBD Through a Novel Pathway
The Bio Report
Writing the Future of Drug Research with Bioink
The Bio Report
An Effort to Develop Safer and More Effective Immunotherapies
The Bio Report
The Year in Biotech and What to Watch in 2019
The Bio Report
Why One Investor Is Betting on Platform Technologies to Change the World
The Bio Report
Price Transparency and a Healthcare Policy Analyst’s Brush with the Healthcare S...
The Bio Report
How a Leading Health Sciences University is Working to Address Homelessness
The Bio Report
Gecko Looks to Broad Applications in Tissue Reconstruction
The Bio Report
The Search for Mediators of Aging
The Bio Report
Using Drug Delivery Technology to Improve ADHD Therapies
The Bio Report
How One Company Is Targeting a Growing Opportunity in Women’s Reproductive Healt...
The Bio Report
Why an HIV Drug in Development Could Change How Cancer Is Treated
The Bio Report
How the Rise of the Patient-Consumer Is Changing Clinical Trials
The Bio Report
Bringing Real-World Monitoring to Autoimmune Disease
The Bio Report
Using Real-World Evidence to Improve Drug Development
The Bio Report
Enlisting Immunotherapies in the Fight Against Infectious Diseases
The Bio Report
Tackling the Problem of Resistance in Chemotherapy
The Bio Report
Engineering Bacteria for Therapeutic Benefit
The Bio Report
The Promise of Organ-on-a-Chip Technology to Improve Drug Development
The Bio Report
Harnessing AI to Fight Diseases of Aging
The Bio Report
Transforming Clinical Trials with Digital Health Technologies
The Bio Report
Why Foresite Capital is Betting Big on the Convergence of AI and Biotech
The Bio Report
Why Public Health Systems Need to Be Better Prepared for Extreme Weather Events
The Bio Report
Predicting the Unpredictable Off-Target Activities of Drugs
The Bio Report
Why Clinics Providing Stem Cell Therapies not Approved by the FDA Are Creating G...
The Bio Report
Making Biomedical Discoveries Sooner
The Bio Report
Reinventing Drug Discovery with AI
The Bio Report
Carrying Therapeutic Payloads Across the Blood-Brain Barrier
The Bio Report
Harnessing Bacteria to Improve Skin Health
The Bio Report
How One Accelerator Tries to Give Early-Stage Drug Developers an Edge
The Bio Report
Making Synthetic Biology a Commercial Reality
The Bio Report
Why Behavioral Economics May Turn Irrational Patients Rational
The Bio Report
Pushing the Frontiers of Longevity
The Bio Report
Is Hearing Loss a Necessary Price for Children to Pay for Life-Saving Chemothera...
The Bio Report
Why Diagnostics May Be Critical to Reshaping Alzheimer’s Drug Development
The Bio Report
Why the Diversity of Genomic Data Matters
The Bio Report
Why Biomarkers May Be the Key to Immuno-Oncology Success
The Bio Report
Seeing Virtue in Patients
The Bio Report
When Science Becomes a Cause
The Bio Report
The Pursuit of Healthier, Safer, and More Humane Meat
The Bio Report
A Hidden Killer and Why Patients Face Barriers to Accessing Promising New Drugs...
The Bio Report
Targeting the Regulators of Genes to Treat Disease
The Bio Report
Price-Fixing Case Against Generic Drugmakers Widens
The Bio Report
Outcomes Erode for Newborns and Mothers in Rural America as Hospitals Lose Obste...
The Bio Report
Why Drug Companies May Soon Become Health Technology Companies
The Bio Report
After Facing Death, Former HR Director Helps Others Get a New Perspective on Lif...
The Bio Report
Putting Physics to Work in the Fight Against Cancer
The Bio Report
Why Aging Might Best Be Thought of as a Disease
The Bio Report
Looking for a Better Alternative to Chemotherapy for AL Amyloidosis
The Bio Report
A University Spin-Out that Incubates University Spin Outs
The Bio Report